New Risk Markers in Atrial Fibrillation

New Risk Markers in Atrial Fibrillation

Atrial fibrillation (AF) confers an independent increased risk of stroke and death. The stroke risk is very heterogeneous and current risk stratification models based on clinical variables, such as the CHADS2 and CHA2DS2VASc score, only offer a modest discriminating value. The aims of this thesis we...

Full description

Bibliographic Details
Main Author:	Hijazi, Ziad
Format:	Doctoral Thesis
Language:	English
Published:	Uppsala universitet, Institutionen för medicinska vetenskaper 2013
Subjects:	atrial fibrillation stroke risk cardiac biomarkers troponin natriuretic peptides NT-proBNP risk stratification
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-198833 http://nbn-resolving.de/urn:isbn:978-91-554-8680-8

Similar Items

N-Terminal Pro B-Type Natriuretic Peptide's Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
by: Elena Palà, et al.
Published: (2019-11-01)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
by: Jayachandran Thejus, et al.
Published: (2009-01-01)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
by: Jan-Thorben Sieweke, et al.
Published: (2020-04-01)

BNP und NT-proBNP als Biomarker zur Detektion von paroxysmalem Vorhofflimmern bei Patienten mit kardiovaskulären Risikofaktoren
by: Grüter, Timo
Published: (2014)

Cardiac Biomarkers in Hyperthyroid Cats
by: Sangster, Jodi Kirsten
Published: (2014)

Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study
by: Jun Xiao, et al.
Published: (2021-03-01)

The Indian Consensus Document on cardiac biomarker
by: I. Satyamurthy, et al.
Published: (2014-01-01)

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
by: Johannes Schnorbach, et al.
Published: (2019-08-01)

Natriuretic peptides: Diagnostic and therapeutic use
by: Kaushik Pandit, et al.
Published: (2011-01-01)

Brain–Heart Axis and Biomarkers of Cardiac Damage and Dysfunction after Stroke: A Systematic Review and Meta-Analysis
by: Chengyang Xu, et al.
Published: (2020-03-01)

Cardiac effects of positive pressure ventilation in ARDS assessed by NT-proBNP, Troponin T and Troponin I
by: Yasser Sadek Nassar, et al.
Published: (2013-01-01)

High sensitivity troponin T and I reflect mitral annular plane systolic excursion being assessed by cardiac magnetic resonance imaging
by: Michèle Natale, et al.
Published: (2017-10-01)

Biological significance of miR-126 expression in atrial fibrillation and heart failure
by: X.J. Wei, et al.
Published: (2015-11-01)

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
by: Stefanie Reynen, et al.
Published: (2021-06-01)

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity
by: F. Fernandes, et al.
Published: (2007-02-01)

Transthoracic echocardiography and cardiac biomarkers in healthy captive male and female squirrel monkeys (Saimiri spp.)
by: Laurent Locquet, et al.
Published: (2020-06-01)

Atrial Fibrillation after Lung Cancer Surgery: Prediction, Prevention and Anticoagulation Management
by: Gennaro Carmine Semeraro, et al.
Published: (2021-08-01)

Laboratory predictors of clinical outcomes in patients with atrial fibrillation
by: A. A. Sokolova, et al.
Published: (2021-05-01)

N‐Terminal pro‐B‐type natriuretic peptide and stroke risk across a spectrum of cerebrovascular disease: The REasons for Geographic and Racial Differences in Stroke cohort
by: Kara K. Landry, et al.
Published: (2020-07-01)

The Usage of Heart Failure Biomarkers in China
by: Xinli Li, MD, PhD, et al.
Published: (2017-02-01)

Influence of preoperative serum N-terminal pro-brain type natriuretic peptide on the postoperative outcome and survival rates of coronary artery bypass patients
by: Thomas Schachner, et al.
Published: (2010-01-01)

Relationship of plasma level of NT- ProBNP with development of AF in CABG patients
by: Tanaray B, et al.
Published: (2010-10-01)

ANALYSIS OF CHANGE IN NT-proBNP AFTER ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY IN PATIENT WITH HEART FAILURE
by: Intan Kusuma Dewi, et al.
Published: (2017-08-01)

Can Circulating Cardiac Biomarkers Be Helpful in the Assessment of <i>LMNA</i> Mutation Carriers?
by: Przemyslaw Chmielewski, et al.
Published: (2020-05-01)

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
by: Clotilde Roy, et al.
Published: (2020-10-01)

Significance of NT-proBNP and High-sensitivity Troponin in Friedreich Ataxia
by: Lise Legrand, et al.
Published: (2020-05-01)

Evaluation of Serum Levels of N-terminal Pro Brain Natriuretic Peptide and Atrial Natriuretic Peptide in Neonates with Respiratory Distress
by: Noor Mohammad Noori, et al.
Published: (2016-06-01)

Using N-terminal pro-B-type natriuretic peptide to diagnose cardiac abnormalities in children with dyspneaen with dyspnea
by: Zakaria Mukalla, et al.
Published: (2017-06-01)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
by: Sofia Hanås, et al.
Published: (2020-05-01)

Chronic heart failure in the practice of the therapist: is it difficult to recognize it?
by: Andrey A. Kirichenko, et al.
Published: (2019-01-01)

ANALYSIS OF CHANGES IN THE SERUM LEVEL NT-proBNP AFTER ACE INHIBITORS THERAPY IN PATIENTS WITH HEART FAILURE
by: Halla Hisan Hartoto, et al.
Published: (2017-08-01)

B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer?
by: Renato de Falco, et al.
Published: (2021-06-01)

Clinical roles of soluble ST2 for the outcomes of cardiac valve operations
by: Robert Chen
Published: (2016-04-01)

Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
by: Lena Hinrichs, et al.
Published: (2020-05-01)

A Clinical Study of the N-Terminal pro-Brain Natriuretic Peptide in Myocardial Injury after Neonatal Asphyxia
by: Rui Zhu, et al.
Published: (2016-04-01)

Kadar N-Terminal Pro-Brain Natriuretic Peptide sebagai Prediktor Luaran Klinis Sindrom Koroner Akut
by: Florencia Idajanti Tandhana, et al.
Published: (2012-06-01)

Incidence of Atrial Fibrillation in Persons with Very High Serum Levels of N-Terminal Pro-B-Type Natriuretic Peptide: The Multi-Ethnic Study of Atherosclerosis
by: Weiss NS, et al.
Published: (2021-04-01)

Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease
by: Jenny Wilshaw, et al.
Published: (2021-03-01)

Left ventricular diastolic dysfunction and N-terminal probrain sodium-uretic peptid level in patients with atrial fibrillation
by: Dzyak G.V., et al.
Published: (2013-06-01)

Diagnosing heart failure in primary care: individual patient data meta‐analysis of two European prospective studies
by: Andrea K. Roalfe, et al.
Published: (2021-06-01)